JP Morgan Chase
ETNB

JP Morgan Chase’s 89bio ETNB Stock Holding History

JP Morgan Chase’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-69,100
Closed -$1.31M – 7530
2023
Q2 		$1.31M Buy
69,100
+53,100
+332% +$932K ﹤0.01% 3847
2023
Q1 		$244K Buy
+16,000
New +$209K ﹤0.01% 4943

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's ETNB Position: Q4 2025 in Review

JP Morgan Chase sold out of 89bio (ETNB) in Q4 2025, closing a stake of 71,178 shares — an estimated $1.05M sold.

JP Morgan Chase first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $8.13M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • JP Morgan Chase reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 71,178 89bio shares in Q4 2025, an estimated $1.05M.
  • JP Morgan Chase first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
  • JP Morgan Chase's 89bio position peaked at $8.13M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.